Leukemia CMPD Panel
Overview
The Leukemia CMPD Panel, performed on bone marrow samples, is a diagnostic test used for the diagnosis of Chronic Myeloproliferative Disorders (CMPDs). This panel includes the detection of JAK2 (V617F) mutation by PCR and BCR-ABL fusion gene by FISH (Fluorescence In Situ Hybridization). The JAK2 (V617F) mutation analysis by PCR is utilized to identify the presence of this specific mutation, which is commonly associated with CMPDs such as Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis. On the other hand, the BCR-ABL fusion gene detection by FISH is utilized to identify the presence of this genetic abnormality, which is associated with Chronic Myeloid Leukemia (CML). These two methods, PCR and FISH, play an important role in the diagnosis and classification of CMPDs, providing valuable information for accurate patient management and treatment decisions.
Leukemia CMPD Panel Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Leukemia CMPD Panel with a clear pricing structure.
The Leukemia CMPD Panel Price in Delhi is ₹ 9,590 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
The Leukaemia CMPD Panel analyzes two genetic markers, JAK-2 (V617F) and BCR-ABL, to identify specific variations in these genes.
• To aid in the diagnosis of Chronic Myeloproliferative Disorders (CMPDs) • To differentiate between different types of leukaemia and make precise treatment plans • To monitor treatment response and disease progression
Your doctor will recommend this test if you • have symptoms like unexplained fatigue, weight loss, or enlarged spleen, • are suspected of CMPD based on your medical history and examination, • have been diagnosed with CML and need to monitor your treatment response, or • have a family history of CMPDs or genetic risk factors.
Abnormal results from the Leukaemia CMPD Panel may suggest the presence of specific genetic variations associated with CMPDs or leukaemia.
During the test, a healthcare professional will draw your bone marrow sample (approximately 3 ml). They will send it for analysis using PCR and FISH methods
• Inform your doctor about any ongoing medications or treatments. Also, tell them if you have any specific requirements. • Provide relevant medical reports and history, which can assist in interpreting your test results accurately.
• Complete Blood Count (CBC): Provides information about various blood cell counts • Bone Marrow Aspiration and Biopsy: Helps evaluate the bone marrow's cellular composition and detect any abnormalities • Molecular Genetic Testing: Identifies specific gene mutations associated with various types of cancer
Chronic Myeloproliferative Disorders (CMPD) Panel or the Leukaemia Genetic Panel
CMPDs are a group of rare blood disorders characterised by the overproduction of blood cells in the bone marrow. These disorders can lead to an increased risk of blood clots, bleeding, and various other complications.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

WhatsApp